Symbio Pharmaceuticals Limited Stock Price Prediction
| SYMQY Stock | USD 0.64 0.00 0.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using SymBio Pharmaceuticals hype-based prediction, you can estimate the value of SymBio Pharmaceuticals Limited from the perspective of SymBio Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in SymBio Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying SymBio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
SymBio Pharmaceuticals after-hype prediction price | USD 0.64 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
SymBio |
SymBio Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of SymBio Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in SymBio Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of SymBio Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
SymBio Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting SymBio Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on SymBio Pharmaceuticals' historical news coverage. SymBio Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.03 and 3.78, respectively. We have considered SymBio Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
SymBio Pharmaceuticals is extremely dangerous at this time. Analysis and calculation of next after-hype price of SymBio Pharmaceuticals is based on 3 months time horizon.
SymBio Pharmaceuticals Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as SymBio Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SymBio Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with SymBio Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.40 | 3.14 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.64 | 0.64 | 0.00 |
|
SymBio Pharmaceuticals Hype Timeline
SymBio Pharmaceuticals is at this time traded for 0.64. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. SymBio is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.4%. %. The volatility of related hype on SymBio Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.64. The book value of the company was at this time reported as 215.28. The company had not issued any dividends in recent years. Assuming the 90 days horizon the next projected press release will be within a week. Check out SymBio Pharmaceuticals Basic Forecasting Models to cross-verify your projections.SymBio Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to SymBio Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict SymBio Pharmaceuticals' future price movements. Getting to know how SymBio Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how SymBio Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GDNSF | Goodness Growth Holdings | 0.00 | 0 per month | 5.79 | (0.01) | 9.09 | (9.59) | 35.45 | |
| EOFBY | Ecofibre Limited | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EEOIF | Elegance Optical International | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BIOGF | Biocartis Group NV | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KIARF | Kiaro Holdings Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HRPMF | Herantis Pharma Oyj | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KDEVF | Karolinska Development AB | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TIHE | Taihe Group | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| INNPF | InnoCan Pharma | 0.00 | 0 per month | 0.00 | (0.25) | 0.00 | (13.46) | 30.69 | |
| ONPPF | Oncopeptides AB | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SymBio Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine SymBio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for SymBio using various technical indicators. When you analyze SymBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About SymBio Pharmaceuticals Predictive Indicators
The successful prediction of SymBio Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as SymBio Pharmaceuticals Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of SymBio Pharmaceuticals based on analysis of SymBio Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to SymBio Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to SymBio Pharmaceuticals's related companies.
Story Coverage note for SymBio Pharmaceuticals
The number of cover stories for SymBio Pharmaceuticals depends on current market conditions and SymBio Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that SymBio Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about SymBio Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for SymBio Pink Sheet Analysis
When running SymBio Pharmaceuticals' price analysis, check to measure SymBio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SymBio Pharmaceuticals is operating at the current time. Most of SymBio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of SymBio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SymBio Pharmaceuticals' price. Additionally, you may evaluate how the addition of SymBio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.